These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6012465)

  • 1. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 4. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methylhydrazine in the treatment of multiple myeloma and Hodgkin's disease].
    Clément F
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1431-4. PubMed ID: 5880926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Hodgkin's disease with Natulan].
    Anglesio E
    Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
    Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
    Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylhydrazine in Hodgkin's disease in reticulosarcoma].
    Finotto E; Grigoletto E; Fiorentino M
    Cancro; 1968; 21(2):165-84. PubMed ID: 4888045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride].
    Berumen L; Franco Guevara G
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):175-82. PubMed ID: 5318927
    [No Abstract]   [Full Text] [Related]  

  • 18. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
    Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
    Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Further observations concerning the results of treatment of Hodgkin's disease and lymphosarcoma with methylhydrazine].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1970 Aug; 23(16):1419-22. PubMed ID: 5468885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.